1. Calasanz MJ, Cigudosa JC. Molecular cytogenetics in translational oncology: when chromosomes meet genomics. Clin Transl Oncol. 2008; 10: 20-29. [
DOI:10.1007/s12094-008-0149-1] [
PMID]
2. American Cancer Society. Breast cancer facts & figures. Atlanta, American Cancer Society Inc. 2007-2008.
3. Center of management of noncontiguous diseases. IRAN Ministry of Health and Medical Education. [Cancer Registry Report]. 2004: 20-55.
4. Miyata M, Furukawa M, Takahashi K, Gonzalez FJ, Yamazoe Y. Mechanism of 7, 12-dimethylbenz [a] anthracene-induced immunotoxicity: Role of metabolic activation at the target organ. Jpn J Pharmacol. 2001; 63: 302-9. [
DOI:10.1254/jjp.86.302] [
PMID]
5. Ueda M, Takagi H, Onodera H, et al. Enhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats. Jpn J Cancer Res. 2002; 93: 752-9. [
DOI:10.1111/j.1349-7006.2002.tb01316.x] [
PMID] [
PMCID]
6. Ciocca DR, Vargas Roig LM. Estrogen reseptors in human nontarget tissues: Biological and clinical implications. Endocrine Reviews. 1995; 16: 35. [
DOI:10.1210/edrv-16-1-35] [
PMID]
7. Ogle TF, Dai D, George P, Mahesh VB. Stromal cell progesterone and estrogen reseptors during proliferation and regression of the decidua basalis in the pregnant rat. Biol Reprod. 1997; 57: 495-506. [
DOI:10.1095/biolreprod57.3.495] [
PMID]
8. Ma DF, Katoh R, Zhou H, Wang PY. Promoting effects of milk on the development of 7, 12-dimethylbenz (a) anthracene (DMBA)-induced mammary tumors in rats. Acta Histochem Cytochem. 2007; 40: 61-7. [
DOI:10.1267/ahc.07008] [
PMID] [
PMCID]
9. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990; 162: 285-94. [
DOI:10.1002/path.1711620403] [
PMID]
10. Vonlanthen S, Kawecki TJ, Betticher DC, Pfefferli M, Schwaller B. Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer. Anticancer Res. 2007; 27: 79-88.
11. Shurbaji MS, Pasternack GR, Kuhajda FP. Expression of haptoglobin-related protein in primary and metastatic breast cancers. A longitudinal study of 48 fatal tumors. Am J Clin Pathol. 1991; 96: 238-42. [
DOI:10.1093/ajcp/96.2.238] [
PMID]
12. Zhang Z, Yamashita H, Toyama T, et al. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Clin Cancer Res. 2005; 11: 191-8.
13. Cho Y, Song JH, Kim CJ, et al. Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res. 2007; 13: 4355-9. [
DOI:10.1158/1078-0432.CCR-07-0619] [
PMID]
14. Dong M, How T, Kirkbride KC, et al. The type III TGF-beta receptor suppresses breast cancer progression. J Clin Invest. 2007; 117: 206-17. [
DOI:10.1172/JCI29293] [
PMID] [
PMCID]
15. Orntoft TF, Meldgaard P, Pedersen B, Wolf H. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res. 1996; 56: 1031-36.
16. Gao S, Worm J, Guldberg P, et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer. 2004; 109: 230-7. [
DOI:10.1002/ijc.11592] [
PMID]
17. Srinivasan D, Sims JT, Plattner R. Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival. Oncogene. 2008; 27: 1095-105. [
DOI:10.1038/sj.onc.1210714] [
PMID]
18. Davoodpour P, Landström M, Welsh M. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein. BMC Cancer. 2007; 7: 61-5. [
DOI:10.1186/1471-2407-7-161] [
PMID] [
PMCID]
19. Yanagawa T, Harada H, Iwasa S, et al. c-Abl expression in oral squamous cell carcinomas. Oral Oncol. 2000; 36: 89-94. [
DOI:10.1016/S1368-8375(99)00067-6]
20. Park HR, Min SK, Cho HD, Kim DH, Shin HS, Park YE. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis. J Korean Med Sci. 2003; 18: 541-6. [
DOI:10.3346/jkms.2003.18.4.541] [
PMID] [
PMCID]
21. Chen. G. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. J Korean Med Sci. 2006; 107: 289-98. [
DOI:10.1002/cncr.21978] [
PMID]
22. Nielsen HL, Ronnov-Jessen L, Villadsen R., Petersen OW. Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics. 2002; 79: 703-10. [
DOI:10.1006/geno.2002.6755] [
PMID]
23. Foran E, McWilliam P, Kelleher D, Croke DT, Long A. The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells. Int J Cancer. 2006; 118: 2098-104. [
DOI:10.1002/ijc.21593] [
PMID]
24. Chung I, Schwartz PE, Crystal RG, Pizzorno G, Leavitt J, Deisseroth AB. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Ther. 1999; 6: 99-106. [
DOI:10.1038/sj.cgt.7700017] [
PMID]
25. Klemke M, Rafael MT, Wabnitz GH, et al. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells. Int J Cancer. 2007; 120: 2590-9. [
DOI:10.1002/ijc.22589] [
PMID]
26. Choi B, Suh Y, Kim WH, Christa L, Park J, Bae CD. Downregulation of regenerating islet-derived 3 alpha (REG3A) in primary human gastric adenocarcinomas. Exp Mol Med. 2007; 39: 796-804. [
DOI:10.1038/emm.2007.86] [
PMID]
27. Zhang L, Anglesio MS, O'Sullivan M, et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med. 2007; 13: 1060-9. [
DOI:10.1038/nm1621] [
PMID]
28. Pasqualucci L, Compagno M, Houldsworth J, et al. Shipp MA, Dalla-Favera R. Inactivation of the PRDM/١BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006; 203: 311-7. [
DOI:10.1084/jem.20052204] [
PMID] [
PMCID]
29. Jaggi M, Rao PS, Smith DJ, Hemstreet GP, Balaji KC. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun. 2003; 307: 254-60. [
DOI:10.1016/S0006-291X(03)01161-6]
30. Lee HJ, Hwang M, Chattopadhyay S, Choi HS, Lee K. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells. Biochem Biophys Res Commun. 2008; 367: 481-6. [
DOI:10.1016/j.bbrc.2007.12.162] [
PMID]
31. Liu X. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells. Clin Cancer Res. 2006; 12: 6337-44. [
DOI:10.1158/1078-0432.CCR-06-0799] [
PMID]
32. Clancy JL, Henderson MJ, Russell AJ, et al. The human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in breast and ovarian cancer. Oncogene. 2003; 22: 5070-81. [
DOI:10.1038/sj.onc.1206775] [
PMID]